{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T06:40:12Z","timestamp":1769841612310,"version":"3.49.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T00:00:00Z","timestamp":1660435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T00:00:00Z","timestamp":1660435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology , Ministry of Science and Technology","doi-asserted-by":"publisher","award":["DBT-ID-2014-2017"],"award-info":[{"award-number":["DBT-ID-2014-2017"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s13402-022-00701-9","type":"journal-article","created":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T14:02:16Z","timestamp":1660485736000},"page":"967-989","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nm23-H1 induces apoptosis in primary effusion lymphoma cells via inhibition of NF-\u03baB signaling through interaction with oncogenic latent protein vFLIP K13 of Kaposi\u2019s sarcoma-associated herpes virus"],"prefix":"10.1007","volume":"45","author":[{"given":"Suchitra","family":"Mohanty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piyanki","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushil Kumar","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ratnadeep","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajagopal","family":"Ramachandranpillai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santhosh Sankaran","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4022-0318","authenticated-orcid":false,"given":"Tathagata","family":"Choudhuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,14]]},"reference":[{"key":"701_CR1","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1182\/blood.V88.2.645.bloodjournal882645","volume":"88","author":"RG Nador","year":"1996","unstructured":"R.G. Nador, E. Cesarman, A. Chadburn, D.B. Dawson, M.Q. Ansari, J. Sald, D.M. Knowles, Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi\u2019s sarcoma-associated herpes virus. Blood 88, 645\u2013656 (1996)","journal-title":"Blood"},{"key":"701_CR2","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/sj.leu.2401390","volume":"13","author":"G Dotti","year":"1999","unstructured":"G. Dotti, R. Fiocchi, T. Motta, B. Facchinetti, B. Chiodini, G.M. Borleri, G. Gavazzeni, T. Barbui, A. Rambaldi, Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8. Leukemia 13, 664\u2013670 (1999)","journal-title":"Leukemia"},{"key":"701_CR3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.annder.2010.01.011","volume":"137","author":"E Regnier-Rosencher","year":"2010","unstructured":"E. Regnier-Rosencher, B. Barrou, A.G. Marcelin, C. Jacobzone-Leveque, J. Cadranel, V. Leblond, C. Frances, Primary effusion lymphoma in two kidney transplant recipients. Ann. Dermatol. Venereol. 137, 285\u2013289 (2010)","journal-title":"Ann. Dermatol. Venereol."},{"key":"701_CR4","doi-asserted-by":"publisher","first-page":"3849","DOI":"10.1016\/j.transproceed.2010.08.039","volume":"42","author":"A Testa","year":"2010","unstructured":"A. Testa, A. Baiocchini, U.V. Comandini, L. Falasca, R. Nardacci, M. Maritti, L. Loiacono, C. Bibbolino, E.B. Rizzi, M. Cristofaro, G.M. Ettorre, G. Vennarecci, G. Antonucci, F. Del Nonno, Fatal sclerosing peritonitis associated with primary effusion lymphoma after liver transplantation: a case report. Transpl. Proc 42, 3849\u20133853 (2010)","journal-title":"Transpl. Proc"},{"key":"701_CR5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.anndiagpath.2012.03.004","volume":"16","author":"Y Kim","year":"2012","unstructured":"Y. Kim, V. Leventaki, F. Bhaijee, C.C. Jackson, L.J. Medeiros, F. Vega, Extracavitary\/solid variant of primary effusion lymphoma. Ann. Diagn. Pathol. 16, 441\u2013446 (2012)","journal-title":"Ann. Diagn. Pathol."},{"key":"701_CR6","doi-asserted-by":"publisher","first-page":"8151","DOI":"10.1128\/jvi.70.11.8151-8154.1996","volume":"70","author":"R Renne","year":"1996","unstructured":"R. Renne, M. Lagunoff, W. Zhong, D. Ganem, The size and conformation of Kaposi\u2019s sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J. Virol. 70, 8151\u20138154 (1996)","journal-title":"J. Virol."},{"key":"701_CR7","doi-asserted-by":"publisher","first-page":"14862","DOI":"10.1073\/pnas.93.25.14862","volume":"93","author":"JJ Russo","year":"1996","unstructured":"J.J. Russo, R.A. Bohenzky, M.C. Chien, J. Chen, M. Yan, D. Maddalena, J.P. Parry, D. Peruzzi, I.S. Edelman, Y. Chang, P.S. Moore, Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. U S A 93, 14862\u201314867 (1996)","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"701_CR8","doi-asserted-by":"publisher","first-page":"5570","DOI":"10.1073\/pnas.0408192102","volume":"102","author":"X Cai","year":"2005","unstructured":"X. Cai, S. Lu, Z. Zhang, C.M. Gonzalez, B. Damania, B.R. Cullen, Kaposi\u2019s sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc. Natl. Acad. Sci. U S A 102, 5570\u20135575 (2005)","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"701_CR9","doi-asserted-by":"crossref","unstructured":"A. Kumar, S.K. Sahu, S. Mohanty, S. Chakrabarti, S. Maji, R.R. Reddy, A.K. Jha, C. Goswami, C.N. Kundu, S. Rajasubramaniam, S.C. Verma, T. Choudhuri, Kaposi sarcoma herpes virus latency associated nuclear antigen protein release the G2\/M cell cycle blocks by modulating ATM\/ATR mediated checkpoint pathway. PLoS One 9, e100228 (2014)","DOI":"10.1371\/journal.pone.0100228"},{"key":"701_CR10","first-page":"140","volume":"1766","author":"A Jarviluoma","year":"2006","unstructured":"A. Jarviluoma, P.M. Ojala, Cell signaling pathways engaged by KSHV. Biochim. Biophys. Acta 1766, 140\u2013158 (2006)","journal-title":"Biochim. Biophys. Acta"},{"key":"701_CR11","unstructured":"S. Mohanty, S.K. Sahu, N.R. Chattopadhyay, A. Kumar, P. Das, T. Choudhuri, TAp63alpha Induced Apoptosis Inhibited by Kaposi\u2019s Sarcoma Herpesvirus Latency Nuclear Antigen. J. Carcinog. Mutagen. 6, 1\u20135 (2015)"},{"key":"701_CR12","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/80459","volume":"6","author":"SA Radkov","year":"2000","unstructured":"S.A. Radkov, P. Kellam, C. Boshoff, The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat. Med. 6, 1121\u20131127 (2000)","journal-title":"Nat. Med."},{"key":"701_CR13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/36606","volume":"390","author":"C Swanton","year":"1997","unstructured":"C. Swanton, D.J. Mann, B. Fleckenstein, F. Neipel, G. Peters, N. Jones, Herpes viral cyclin\/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature 390, 184\u2013187 (1997)","journal-title":"Nature"},{"key":"701_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S1359-6101(00)00029-0","volume":"12","author":"J Choi","year":"2001","unstructured":"J. Choi, R.E. Means, B. Damania, J.U. Jung, Molecular piracy of Kaposi\u2019s sarcoma associated herpesvirus. Cytokine Growth Factor Rev 12, 245\u2013257 (2001)","journal-title":"Cytokine Growth Factor Rev"},{"key":"701_CR15","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/386517a0","volume":"386","author":"M Thome","year":"1997","unstructured":"M. Thome, P. Schneider, K. Hofmann, H. Fickenscher, E. Meinl, F. Neipel, C. Mattmann, K. Burns, J.L. Bodmer, M. Schroter, C. Scaffidi, P.H. Krammer, M.E. Peter, J. Tschopp, Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386, 517\u2013521 (1997)","journal-title":"Nature"},{"key":"701_CR16","first-page":"62","volume":"4","author":"C Belanger","year":"2001","unstructured":"C. Belanger, A. Gravel, A. Tomoiu, M.E. Janelle, J. Gosselin, M.J. Tremblay, L. Flamand, Human herpesvirus 8 viral FLICE-inhibitory protein inhibits Fas-mediated apoptosis through binding and prevention of procaspase-8 maturation. J. Hum. Virol. 4, 62\u201373 (2001)","journal-title":"J. Hum. Virol."},{"key":"701_CR17","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1182\/blood-2002-07-2072","volume":"101","author":"Q Sun","year":"2003","unstructured":"Q. Sun, H. Matta, P.M. Chaudhary, He human herpes virus 8-encoded viral FLICE inhibitory protein protects against growth factor withdrawal-induced apoptosis via NF-kappa B activation. Blood 101, 1956\u20131961 (2003)","journal-title":"Blood"},{"key":"701_CR18","doi-asserted-by":"publisher","first-page":"5738","DOI":"10.1038\/sj.onc.1202976","volume":"18","author":"PM Chaudhary","year":"1999","unstructured":"P.M. Chaudhary, A. Jasmin, M.T. Eby, L. Hood, Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins. Oncogene 18, 5738\u20135746 (1999)","journal-title":"Oncogene"},{"key":"701_CR19","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.1242\/jcs.00691","volume":"116","author":"N Field","year":"2003","unstructured":"N. Field, W. Low, M. Daniels, S. Howell, L. Daviet, C. Boshoff, M. Collins, KSHV vFLIP binds to IKK-gamma to activate IKK. J. Cell. Sci. 116, 3721\u20133728 (2003)","journal-title":"J. Cell. Sci."},{"key":"701_CR20","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1182\/blood.V96.7.2537.h8002537_2537_2542","volume":"96","author":"SA Keller","year":"2000","unstructured":"S.A. Keller, E.J. Schattner, E. Cesarman, Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood 96, 2537\u20132542 (2000)","journal-title":"Blood"},{"key":"701_CR21","doi-asserted-by":"publisher","first-page":"13745","DOI":"10.1074\/jbc.M110480200","volume":"277","author":"L Liu","year":"2002","unstructured":"L. Liu, M.T. Eby, N. Rathore, S.K. Sinha, A. Kumar, P.M. Chaudhary, The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex. J. Biol. Chem. 277, 13745\u201313751 (2002)","journal-title":"J. Biol. Chem."},{"key":"701_CR22","doi-asserted-by":"publisher","first-page":"52437","DOI":"10.1074\/jbc.M304199200","volume":"278","author":"Q Sun","year":"2003","unstructured":"Q. Sun, S. Zachariah, P.M. Chaudhary, The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-kappaB activation. J. Biol. Chem. 278, 52437\u201352445 (2003)","journal-title":"J. Biol. Chem."},{"key":"701_CR23","doi-asserted-by":"publisher","first-page":"9399","DOI":"10.1073\/pnas.0308016101","volume":"101","author":"H Matta","year":"2004","unstructured":"H. Matta, P.M. Chaudhary, Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP). Proc. Natl. Acad. Sci. U S A 101, 9399\u20139404 (2004)","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"701_CR24","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1182\/blood.V96.4.1599.h8001599_1599_1601","volume":"96","author":"Y Aoki","year":"2000","unstructured":"Y. Aoki, R. Yarchoan, J. Braun, A. Iwamoto, G. Tosato, Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions. Blood 96, 1599\u20131601 (2000)","journal-title":"Blood"},{"key":"701_CR25","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1182\/blood.V94.8.2871.420k25_2871_2879","volume":"94","author":"KD Jones","year":"1999","unstructured":"K.D. Jones, Y. Aoki, Y. Chang, P.S. Moore, R. Yarchoan, G. Tosato, Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi\u2019s sarcoma herpesvirus-associated infected primary effusion lymphoma cells. Blood 94, 2871\u20132879 (1999)","journal-title":"Blood"},{"key":"701_CR26","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1038\/sj.onc.1206407","volume":"22","author":"J An","year":"2003","unstructured":"J. An, Y. Sun, R. Sun, M.B. Rettig, Kaposi\u2019s sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-kappaB and JNK\/AP1 pathways. Oncogene 22, 3371\u20133385 (2003)","journal-title":"Oncogene"},{"key":"701_CR27","doi-asserted-by":"publisher","first-page":"e37498","DOI":"10.1371\/journal.pone.0037498","volume":"7","author":"V Punj","year":"2012","unstructured":"V. Punj, H. Matta, P.M. Chaudhary, A computational profiling of changes in gene expression and transcription factors induced by vFLIP K13 in primary effusion lymphoma. PLoS One 7, e37498 (2012)","journal-title":"PLoS One"},{"key":"701_CR28","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.1200\/JCO.2005.07.084","volume":"23","author":"E Boulanger","year":"2005","unstructured":"E. Boulanger, L. Gerard, J. Gabarre, J.M. Molina, C. Rapp, J.F. Abino, J. Cadranel, S. Chevret, E. Oksenhendler, Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS. J. Clin. Oncol. 23, 4372\u20134380 (2005)","journal-title":"J. Clin. Oncol."},{"key":"701_CR29","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/jnci\/80.3.200","volume":"80","author":"PS Steeg","year":"1988","unstructured":"P.S. Steeg, G. Bevilacqua, L. Kopper, U.P. Thorgeirsson, J.E. Talmadge, L.A. Liotta, M.E. Sobel, Evidence for a novel gene associated with low tumor metastatic potential. J. Natl. Cancer Inst. 80, 200\u2013204 (1988)","journal-title":"J. Natl. Cancer Inst."},{"key":"701_CR30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1023\/A:1005549315846","volume":"32","author":"N Kimura","year":"2000","unstructured":"N. Kimura, N. Shimada, M. Fukuda, Y. Ishijima, H. Miyazaki, A. Ishii, Y. Takagi, N. Ishikawa, Regulation of cellular functions by nucleoside diphosphate kinases in mammals. J. Bioenerg. Biomembr. 32, 309\u2013315 (2000)","journal-title":"J. Bioenerg Biomembr."},{"key":"701_CR31","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/(SICI)1097-0142(19970315)79:6<1158::AID-CNCR14>3.0.CO;2-Z","volume":"79","author":"RL Russell","year":"1997","unstructured":"R.L. Russell, K.R. Geisinger, R.R. Mehta, W.L. White, B. Shelton, T.E. Kute, NM23-relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients. Cancer 79, 1158\u20131165 (1997)","journal-title":"Cancer"},{"key":"701_CR32","first-page":"6550","volume":"48","author":"PS Steeg","year":"1988","unstructured":"P.S. Steeg, G. Bevilacqua, R. Pozzatti, L.A. Liotta, M.E. Sobel, Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis. Cancer Res. 48, 6550\u20136554 (1988)","journal-title":"Cancer Res."},{"key":"701_CR33","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/sj.bjc.6604167","volume":"98","author":"SJ Liu","year":"2008","unstructured":"S.J. Liu, Y.M. Sun, D.F. Tian, Y.C. He, L. Zeng, Y. He, C.Q. Ling, S.H. Sun, Downregulated NM23-H1 expression is associated with intracranial invasion of nasopharyngeal carcinoma. Br. J. Cancer 98, 363\u2013369 (2008)","journal-title":"Br. J. Cancer"},{"key":"701_CR34","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1172\/JCI115299","volume":"88","author":"N Hailat","year":"1991","unstructured":"N. Hailat, D.R. Keim, R.F. Melhem, X.X. Zhu, C. Eckerskorn, G.M. Brodeur, C.P. Reynolds, R.C. Seeger, F. Lottspeich, J.R. Strahler, et al., High levels of p19\/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J. Clin. Invest. 88, 341\u2013345 (1991)","journal-title":"J. Clin. Invest."},{"key":"701_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.leukres.2018.01.003","volume":"66","author":"J Okabe-Kado","year":"2018","unstructured":"J. Okabe-Kado, Y. Hagiwara-Watanabe, N. Niitsu, T. Kasukabe, Y. Kaneko, NM23 downregulation and lysophosphatidic acid receptor EDG2\/lpa1 upregulation during myeloid differentiation of human leukemia cells. Leuk. Res. 66, 39\u201348 (2018)","journal-title":"Leuk. Res."},{"key":"701_CR36","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1086\/301942","volume":"63","author":"MT Hartsough","year":"1998","unstructured":"M.T. Hartsough, P.S. Steeg, Nm23-H1: genetic alterations and expression patterns in tumor metastasis. Am. J. Hum. Genet. 63, 6\u201310 (1998)","journal-title":"Am. J. Hum. Genet."},{"key":"701_CR37","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10863-006-9037-y","volume":"38","author":"AM Mileo","year":"2006","unstructured":"A.M. Mileo, E. Piombino, A. Severino, A. Tritarelli, M.G. Paggi, D. Lombardi, Multiple interference of the human papillomavirus-16 E7 oncoprotein with the functional role of the metastasis suppressor Nm23-H1 protein. J. Bioenerg. Biomembr. 38, 215\u2013225 (2006)","journal-title":"J. Bioenerg Biomembr."},{"key":"701_CR38","doi-asserted-by":"publisher","first-page":"8702","DOI":"10.1128\/JVI.76.17.8702-8709.2002","volume":"76","author":"C Subramanian","year":"2002","unstructured":"C. Subramanian, E.S. Robertson, The metastatic suppressor Nm23-H1 interacts with EBNA3C at sequences located between the glutamine- and proline-rich domains and can cooperate in activation of transcription. J. Virol. 76, 8702\u20138709 (2002)","journal-title":"J. Virol."},{"key":"701_CR39","doi-asserted-by":"publisher","first-page":"4871","DOI":"10.1128\/JVI.02286-08","volume":"83","author":"R Kaul","year":"2009","unstructured":"R. Kaul, M. Murakami, K. Lan, T. Choudhuri, E.S. Robertson, EBNA3C can modulate the activities of the transcription factor Necdin in association with metastasis suppressor protein Nm23-H1. J. Virol. 83, 4871\u20134883 (2009)","journal-title":"J. Virol."},{"key":"701_CR40","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.virol.2006.03.031","volume":"351","author":"T Choudhuri","year":"2006","unstructured":"T. Choudhuri, S.C. Verma, K. Lan, E.S. Robertson, Expression of alpha V integrin is modulated by Epstein-Barr virus nuclear antigen 3\u00a0C and the metastasis suppressor Nm23-H1 through interaction with the GATA-1 and Sp1 transcription factors. Virology 351, 58\u201372 (2006)","journal-title":"Virology"},{"key":"701_CR41","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0014-5793(00)01681-1","volume":"475","author":"JL Scarlett","year":"2000","unstructured":"J.L. Scarlett, P.W. Sheard, G. Hughes, E.C. Ledgerwood, H.H. Ku, M.P. Murphy, Hanges in mitochondrial membrane potential during staurosporine-induced apoptosis in Jurkat cells. FEBS Lett. 475, 267\u2013272 (2000)","journal-title":"FEBS Lett."},{"key":"701_CR42","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1084\/jem.182.2.367","volume":"182","author":"N Zamzami","year":"1995","unstructured":"N. Zamzami, P. Marchetti, M. Castedo, D. Decaudin, A. Macho, T. Hirsch, S.A. Susin, P.X. Petit, B. Mignotte, G. Kroemer, Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182, 367\u2013377 (1995)","journal-title":"J. Exp. Med."},{"key":"701_CR43","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/(SICI)1097-0320(19970401)27:4<358::AID-CYTO7>3.0.CO;2-8","volume":"27","author":"M Poot","year":"1997","unstructured":"M. Poot, L.L. Gibson, V.L. Singer, Detection of apoptosis in live cells by MitoTracker red CMXRos and SYTO dye flow cytometry. Cytometry 27, 358\u2013364 (1997)","journal-title":"Cytometry"},{"key":"701_CR44","doi-asserted-by":"crossref","unstructured":"S. Mohanty, A. Kumar, P. Das, S.K. Sahu, T. Choudhuri, Multi-targeted therapy of everolimus in Kaposi\u2019s sarcoma associated herpes virus infected primary effusion lymphoma. Apoptosis 22, 1098\u20131115 (2017)","DOI":"10.1007\/s10495-017-1391-1"},{"key":"701_CR45","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.tim.2010.04.001","volume":"18","author":"DE de Oliveira","year":"2010","unstructured":"D.E. de Oliveira, G. Ballon, E. Cesarman, NF-kappaB signaling modulation by EBV and KSHV. Trends Microbiol. 18, 248\u2013257 (2010)","journal-title":"Trends Microbiol."},{"key":"701_CR46","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1182\/blood-2005-07-2730","volume":"107","author":"SA Keller","year":"2006","unstructured":"S.A. Keller, D. Hernandez-Hopkins, J. Vider, V. Ponomarev, E. Hyjek, E.J. Schattner, E. Cesarman, NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo. Blood 107, 3295\u20133302 (2006)","journal-title":"Blood"},{"key":"701_CR47","doi-asserted-by":"publisher","first-page":"5016","DOI":"10.1158\/1078-0432.CCR-12-3510","volume":"19","author":"R Gopalakrishnan","year":"2013","unstructured":"R. Gopalakrishnan, H. Matta, P.M. Chaudhary, A purine scaffold HSP90 inhibitor BIIB021 has selective activity against KSHV-associated primary effusion lymphoma and blocks vFLIP K13-induced NF-kappaB. Clin. Cancer Res. 19, 5016\u20135026 (2013)","journal-title":"Clin. Cancer Res."},{"key":"701_CR48","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jim.2006.01.018","volume":"311","author":"TC George","year":"2006","unstructured":"T.C. George, S.L. Fanning, P. Fitzgerald-Bocarsly, R.B. Medeiros, S. Highfill, Y. Shimizu, B.E. Hall, K. Frost, D. Basiji, W.E. Ortyn, P.J. Morrissey, D.H. Lynch, Quantitative measurement of nuclear translocation events using similarity analysis of multispectral cellular images obtained in flow. J. Immunol. Methods 311, 117\u2013129 (2006)","journal-title":"J. Immunol. Methods"},{"key":"701_CR49","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/cyto.a.21068","volume":"79","author":"O Maguire","year":"2011","unstructured":"O. Maguire, C. Collins, K. O\u2019Loughlin, J. Miecznikowski, H. Minderman, Quantifying nuclear p65 as a parameter for NF-kappaB activation: Correlation between ImageStream cytometry, microscopy, and Western blot. Cytometry A 79, 461\u2013469 (2011)","journal-title":"Cytometry A"},{"key":"701_CR50","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1177\/1087057110370894","volume":"15","author":"A Shariff","year":"2010","unstructured":"A. Shariff, J. Kangas, L.P. Coelho, S. Quinn, R.F. Murphy, Automated image analysis for high-content screening and analysis. J. Biomol. Screen. 15, 726\u2013734 (2010)","journal-title":"J. Biomol. Screen."},{"key":"701_CR51","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/B978-0-12-374912-3.00008-0","volume":"102","author":"EK Zuba-Surma","year":"2011","unstructured":"E.K. Zuba-Surma, M.Z. Ratajczak, Analytical capabilities of the ImageStream cytometer. Methods Cell. Biol. 102, 207\u2013230 (2011)","journal-title":"Methods Cell. Biol."},{"key":"701_CR52","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1128\/JVI.01596-10","volume":"85","author":"Z Qin","year":"2011","unstructured":"Z. Qin, L. Dai, B. Toole, E. Robertson, C. Parsons, Regulation of Nm23-H1 and cell invasiveness by Kaposi\u2019s sarcoma-associated herpesvirus. J. Virol. 85, 3596\u20133606 (2011)","journal-title":"J. Virol."},{"key":"701_CR53","doi-asserted-by":"crossref","unstructured":"S. Mohanty, E.W. Harhaj, Mechanisms of Oncogenesis by HTLV-1 Tax. Pathogens. 9, 1\u201328 (2020)","DOI":"10.3390\/pathogens9070543"},{"key":"701_CR54","first-page":"334","volume":"7","author":"F Wei","year":"2016","unstructured":"F. Wei, J. Gan, C. Wang, C. Zhu, Q. Cai, Cell. Cycle Regulatory Functions of the KSHV Oncoprotein LANA Front. Microbiol. 7, 334 (2016)","journal-title":"Cell. Cycle Regulatory Functions of the KSHV Oncoprotein LANA Front. Microbiol."},{"key":"701_CR55","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/sj.cgt.7700899","volume":"13","author":"J Li","year":"2006","unstructured":"J. Li, J. Zhou, G. Chen, H. Wang, S. Wang, H. Xing, Q. Gao, Y. Lu, Y. He, D. Ma, Inhibition of ovarian cancer metastasis by adeno-associated virus-mediated gene transfer of nm23H1 in an orthotopic implantation model. Cancer Gene. Ther. 13, 266\u2013272 (2006)","journal-title":"Cancer Gene Ther"},{"key":"701_CR56","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/cgt.2008.97","volume":"16","author":"Z Li","year":"2009","unstructured":"Z. Li, J. Xiang, W. Zhang, S. Fan, M. Wu, X. Li, G. Li, Nanoparticle delivery of anti-metastatic NM23-H1 gene improves chemotherapy in a mouse tumor model. Cancer Gene. Ther. 16, 423\u2013429 (2009)","journal-title":"Cancer Gene Ther"},{"key":"701_CR57","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0092-8674(03)00150-8","volume":"112","author":"Z Fan","year":"2003","unstructured":"Z. Fan, P.J. Beresford, D.Y. Oh, D. Zhang, J. Lieberman, Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell 112, 659\u2013672 (2003)","journal-title":"Cell"},{"key":"701_CR58","doi-asserted-by":"crossref","unstructured":"Q.L. Cai, J.S. Knight, S.C. Verma, P. Zald, E.S. Robertson, EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors. PLoS Pathog. 2, e116 (2006)","DOI":"10.1371\/journal.ppat.0020116"},{"key":"701_CR59","doi-asserted-by":"crossref","unstructured":"F. Ye, X. Lei, S.J. Gao, Mechanisms of Kaposi\u2019s Sarcoma-Associated Herpesvirus Latency and Reactivation. Adv. Virol 2011, 1\u201319 (2011)","DOI":"10.1155\/2011\/193860"},{"key":"701_CR60","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/v7010116","volume":"7","author":"P Purushothaman","year":"2015","unstructured":"P. Purushothaman, T. Uppal, S.C. Verma, Molecular biology of KSHV lytic reactivation. Viruses 7, 116\u2013153 (2015)","journal-title":"Viruses"},{"key":"701_CR61","doi-asserted-by":"publisher","first-page":"12438","DOI":"10.1038\/s41598-017-12676-x","volume":"7","author":"A Kumar","year":"2017","unstructured":"A. Kumar, S. Mohanty, P. Das, S.K. Sahu, S. Rajasubramaniam, T. Choudhuri, 1, 25(OH)2 D3 Induces Reactivation and Death of Kaposi\u2019s Sarcoma-Associated Herpesvirus of Primary Effusion Lymphoma cells. Sci. Rep. 7, 12438 (2017)","journal-title":"Sci. Rep."},{"key":"701_CR62","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/onc.2012.118","volume":"32","author":"G Sarek","year":"2013","unstructured":"G. Sarek, L. Ma, J. Enback, A. Jarviluoma, P. Moreau, J. Haas, A. Gessain, P.J. Koskinen, P. Laakkonen, P.M. Ojala, Kaposi\u2019s sarcoma herpesvirus lytic replication compromises apoptotic response to p53 reactivation in virus-induced lymphomas. Oncogene 32, 1091\u20131098 (2013)","journal-title":"Oncogene"},{"key":"701_CR63","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.4161\/cc.19756","volume":"11","author":"F Ye","year":"2012","unstructured":"F. Ye, A.A. Lattif, J. Xie, A. Weinberg, S. Gao, Nutlin-3 induces apoptosis, disrupts viral latency and inhibits expression of angiopoietin-2 in Kaposi sarcoma tumor cells. Cell. Cycle 11, 1393\u20131399 (2012)","journal-title":"Cell. Cycle"},{"key":"701_CR64","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1084\/jem.190.7.1025","volume":"190","author":"M Djerbi","year":"1999","unstructured":"M. Djerbi, V. Screpanti, A.I. Catrina, B. Bogen, P. Biberfeld, A. Grandien, The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J. Exp. Med. 190, 1025\u20131032 (1999)","journal-title":"J. Exp. Med."},{"key":"701_CR65","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1128\/JVI.01393-12","volume":"87","author":"C Graham","year":"2013","unstructured":"C. Graham, H. Matta, Y. Yang, H. Yi, Y. Suo, B. Tolani, P.M. Chaudhary, Kaposi\u2019s sarcoma-associated herpesvirus oncoprotein K13 protects against B cell receptor-induced growth arrest and apoptosis through NF-kappaB activation. J. Virol. 87, 2242\u20132252 (2013)","journal-title":"J. Virol."},{"key":"701_CR66","doi-asserted-by":"publisher","first-page":"6867","DOI":"10.1038\/sj.onc.1203219","volume":"18","author":"M Karin","year":"1999","unstructured":"M. Karin, How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 18, 6867\u20136874 (1999)","journal-title":"Oncogene"},{"key":"701_CR67","doi-asserted-by":"publisher","first-page":"24858","DOI":"10.1074\/jbc.M700118200","volume":"282","author":"H Matta","year":"2007","unstructured":"H. Matta, L. Mazzacurati, S. Schamus, T. Yang, Q. Sun, P.M. Chaudhary, Kaposi\u2019s sarcoma-associated herpesvirus (KSHV) oncoprotein K13 bypasses TRAFs and directly interacts with the IkappaB kinase complex to selectively activate NF-kappaB without JNK activation. J. Biol. Chem. 282, 24858\u201324865 (2007)","journal-title":"J. Biol. Chem."},{"key":"701_CR68","doi-asserted-by":"crossref","unstructured":"H. Matta, R. Gopalakrishnan, C. Graham, B. Tolani, A. Khanna, H. Yi, Y. Suo, P.M. Chaudhary, Kaposi\u2019s sarcoma associated herpesvirus encoded viral FLICE inhibitory protein K13 activates NF-kappaB pathway independent of TRAF6, TAK1 and LUBAC. PLoS One 7, e36601 (2012)","DOI":"10.1371\/journal.pone.0036601"},{"key":"701_CR69","doi-asserted-by":"crossref","unstructured":"R. Hunte, P. Alonso, R. Thomas, C.A. Bazile, J.C. Ramos, L. van der Weyden, J. Dominguez-Bendala, W.N. Khan, N. Shembade, CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-kappaB activation. PLoS Pathog. 14, e1006968 (2018)","DOI":"10.1371\/journal.ppat.1006968"},{"key":"701_CR70","doi-asserted-by":"publisher","first-page":"21555","DOI":"10.1074\/jbc.M111.224048","volume":"286","author":"H Matta","year":"2011","unstructured":"H. Matta, R. Gopalakrishnan, V. Punj, H. Yi, Y. Suo, P.M. Chaudhary, A20 is induced by Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 and blocks K13-induced nuclear factor-kappaB in a negative feedback manner. J. Biol. Chem. 286, 21555\u201321564 (2011)","journal-title":"J. Biol. Chem."},{"key":"701_CR71","doi-asserted-by":"publisher","first-page":"17709","DOI":"10.1074\/jbc.M114.553552","volume":"289","author":"DJ You","year":"2014","unstructured":"D.J. You, C.R. Park, H.B. Lee, M.J. Moon, J.H. Kang, C. Lee, S.H. Oh, C. Ahn, J.Y. Seong, J.I. Hwang, A splicing variant of NME1 negatively regulates NF-kappaB signaling and inhibits cancer metastasis by interacting with IKKbeta. J. Biol. Chem. 289, 17709\u201317720 (2014)","journal-title":"J. Biol. Chem."},{"key":"701_CR72","doi-asserted-by":"crossref","unstructured":"E.S. Ehrlich, J.C. Chmura, J.C. Smith, N.N. Kalu, G.S. Hayward, KSHV RTA abolishes NFkappaB responsive gene expression during lytic reactivation by targeting vFLIP for degradation via the proteasome. PLoS One 9, e91359 (2014)","DOI":"10.1371\/journal.pone.0091359"},{"key":"701_CR73","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1038\/s41418-018-0268-3","volume":"26","author":"X Ding","year":"2019","unstructured":"X. Ding, J. Xu, C. Wang, Q. Feng, Q. Wang, Y. Yang, H. Lu, F. Wang, K. Zhu, W. Li, Q. Yan, S.J. Gao, C. Lu, Suppression of the SAP18\/HDAC1 complex by targeting TRIM56 and Nanog is essential for oncogenic viral FLICE-inhibitory protein-induced acetylation of p65\/RelA, NF-kappaB activation, and promotion of cell invasion and angiogenesis. Cell. Death Differ. 26, 1970\u20131986 (2019)","journal-title":"Cell. Death Differ."},{"key":"701_CR74","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1349-7006.2012.02212.x","volume":"103","author":"H Goto","year":"2012","unstructured":"H. Goto, R. Kariya, M. Shimamoto, E. Kudo, M. Taura, H. Katano, S. Okada, Antitumor effect of berberine against primary effusion lymphoma via inhibition of NF-kappaB pathway. Cancer Sci. 103, 775\u2013781 (2012)","journal-title":"Cancer Sci."},{"key":"701_CR75","doi-asserted-by":"crossref","unstructured":"L. Dai, J. Trillo-Tinoco, L. Bai, B. Kang, Z. Xu, X. Wen, L. Del Valle, Z. Qin, Systematic analysis of a xenograft mice model for KSHV + primary effusion lymphoma (PEL). PLoS One 9, e90349 (2014)","DOI":"10.1371\/journal.pone.0090349"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-022-00701-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-022-00701-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-022-00701-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T18:04:17Z","timestamp":1666116257000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-022-00701-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,14]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["701"],"URL":"https:\/\/doi.org\/10.1007\/s13402-022-00701-9","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,14]]},"assertion":[{"value":"31 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/competing interests"}},{"value":"This study was approved by the ethics committee of the Institute of Life Sciences, Bhubaneswar, India and signed informed consent was obtained from all the healthy blood donors. The animal experiments were approved by the animal ethics committee of Rajiv Gandhi Centre for Biotechnology, Trivandrum, India (IAEC\/199\/SANT\/2013).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}